- Home
- ALHC
as 03-25-2025 4:00pm EST
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | ORANGE |
| Market Cap: | 3.1B | IPO Year: | 2021 |
| Target Price: | $15.35 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.67 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.46 - $17.80 | Next Earning Date: | 05-01-2025 |
| Revenue: | $2,703,561,000 | Revenue Growth: | 48.25% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 25.16% |
Stock Insider Trading Activity of Alignment Healthcare Inc. (ALHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kim Hyong | ALHC | Chief Medical Officer | Mar 19 '25 | Sell | $16.52 | 8,266 | $135,570.55 | 536,101 | |
| Burzacchi Sebastian | ALHC | COO - Mgmt Services Org | Mar 19 '25 | Sell | $16.52 | 6,694 | $109,788.22 | 252,784 | |
| Scavo Robert L. | ALHC | Chief Information Officer | Mar 18 '25 | Sell | $16.65 | 11,157 | $184,906.50 | 705,817 | |
| Freeman Robert Thomas | ALHC | Chief Financial Officer | Mar 18 '25 | Sell | $16.65 | 25,247 | $420,838.90 | 1,471,163 | |
| Kardes Hakan | ALHC | Chief Experience Officer | Mar 18 '25 | Sell | $16.68 | 31,602 | $533,471.88 | 692,814 | |
| Maroney Dawn Christine | ALHC | President | Mar 18 '25 | Sell | $16.65 | 43,649 | $729,161.10 | 2,390,586 | |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | Mar 18 '25 | Sell | $16.65 | 17,741 | $294,262.19 | 451,038 | |
| Maroney Dawn Christine | ALHC | President | Mar 13 '25 | Sell | $15.99 | 30,000 | $479,688.00 | 2,390,586 | |
| Scavo Robert L. | ALHC | Chief Information Officer | Mar 12 '25 | Sell | $15.58 | 5,313 | $81,966.54 | 705,817 | |
| Freeman Robert Thomas | ALHC | Chief Financial Officer | Mar 12 '25 | Sell | $15.58 | 14,692 | $226,661.66 | 1,471,163 |
Latest Alignment Healthcare Inc. News
ALHC Breaking Stock News: Dive into ALHC Ticker-Specific Updates for Smart Investing
StockStory
a day ago
2 Reasons to Like ALHC and 1 to Stay Skeptical
Investor's Business Daily
4 days ago
These Seven Risky Bets Take The Shine Off Gold; One Looks To Extend 46% Gain
StockStory
4 days ago
Healthcare Providers & Services Stocks Q4 Teardown: Cardinal Health (NYSE:CAH) Vs The Rest
MT Newswires
6 days ago
Alignment Healthcare Insider Sold Shares Worth $1,024,371, According to a Recent SEC Filing
TipRanks
6 days ago
Alignment Healthcare, Sutter Health renew long-term, strategic collaboration
GlobeNewswire
7 days ago
Sutter Health and Alignment Healthcare Renew Long-Term, Strategic Collaboration
StockStory
7 days ago
Q4 Earnings Outperformers: Clover Health (NASDAQ:CLOV) And The Rest Of The Health Insurance Providers Stocks
MT Newswires
12 days ago
Alignment Healthcare Insider Sold Shares Worth $420,293, According to a Recent SEC Filing
Compare ALHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALHC Alignment Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.